Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event :
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
  • Shine Speaker Bureau:
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
  • Shine Advisor:
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
  • Shine Event Service:
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
Guest Information
Pele CHONG
Pele CHONG
Positions:

Chief Operation Officer

Company:

BravoVax Co., Ltd

Dr. Chong obtained his BSc (1978) and PhD (1983) from the department of Biochemistry in the University of Alberta, Edmonton, Canada. He was trained as a protein chemist and specialized in peptide synthesis for protein structure and function studies. After 2 years as a MRC postdoctoral in the University of British Columbia, Dr. Chong moved to Toronto and had spent 15 years at Connaught Laboratory Limited (now called Sanofi Pasteur) in human vaccine research and development. During his tenure there as a Research Scientist (July/1985) and Director (July/1994), Dr. Chong had developed two human vaccines, ProHibit against H. influenzae type b (Hib) and the component pertussis vaccine, and also took a synthetic peptide-based HIV vaccine to Phase I clinical trials in 1994.  Dr. Chong moved to New York in 2000 and joined United Biomedical Inc. (UBI) where he helped developing a peptide-based animal Foot-Mouth Disease vaccine for pig that is currently licensed in China. Dr. Chong was recruited and joined NHRI in 2003 and as the founder established the Vaccine Research and Development Center (VRDC). To facilitate and implement the Taiwanese Government Vaccine R&D, Self-Manufacturing and Supply strategic plans, Dr. Chong had developed and took both cell-based H5N1 flu vaccine and EV71 vaccine to phase I clinical trials. In March 2018, Dr. Chong joined BravoVax, Wuhan. Dr. Chong has authored over 200 original research articles and has over 80 patents filed and/or granted.